Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliott Vichinsky

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Frontiers in Neurology|June 6, 2024
Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trialSuzanne Braniecki, Elliott Vichinsky, Mark C Walters, et al.
British Journal of Haematology|September 12, 2014
Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patientsJohn B Porter, Patrick B Walter, Lynne D Neumayr, et al.
British Journal of Haematology|November 20, 2020
A complication risk score to evaluate clinical severity of thalassaemia syndromesAngela Vitrano, Antonella Meloni, Walter Addario Pollina, et al.
Clinical Therapeutics|August 19, 2007
Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemiaMaria Domenica Cappellini, Mohamed Bejaoui, Leyla Agaoglu, et al.
Blood Advances|November 8, 2021
Consensus statement for the perinatal management of patients with α thalassemia majorTippi C MacKenzie, Ali Amid, Michael Angastiniotis, et al.
Blood Advances|July 11, 2024
COVID-19 mRNA vaccination responses in individuals with sickle cell disease: an ASH RC Sickle Cell Research Network StudyAlan R Anderson, John J Strouse, Deepa Manwani, et al.
The Journal of Pediatrics|October 23, 2003
Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccinationThomas V Adamkiewicz, Sharada Sarnaik, George R Buchanan, et al.
The New England Journal of Medicine|June 15, 2019
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell DiseaseElliott Vichinsky, Carolyn C Hoppe, Kenneth I Ataga, et al.
Blood|September 2, 2009
Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injuryThomas V Adamkiewicz, Miguel R Abboud, Carole Paley, et al.
Trials|August 16, 2023
Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trialChris A Rees, David C Brousseau, Daniel M Cohen, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Frontiers in Neurology|June 6, 2024
Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trialSuzanne Braniecki, Elliott Vichinsky, Mark C Walters, et al.
British Journal of Haematology|September 12, 2014
Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patientsJohn B Porter, Patrick B Walter, Lynne D Neumayr, et al.
British Journal of Haematology|November 20, 2020
A complication risk score to evaluate clinical severity of thalassaemia syndromesAngela Vitrano, Antonella Meloni, Walter Addario Pollina, et al.
Clinical Therapeutics|August 19, 2007
Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemiaMaria Domenica Cappellini, Mohamed Bejaoui, Leyla Agaoglu, et al.
Blood Advances|November 8, 2021
Consensus statement for the perinatal management of patients with α thalassemia majorTippi C MacKenzie, Ali Amid, Michael Angastiniotis, et al.
Blood Advances|July 11, 2024
COVID-19 mRNA vaccination responses in individuals with sickle cell disease: an ASH RC Sickle Cell Research Network StudyAlan R Anderson, John J Strouse, Deepa Manwani, et al.
The Journal of Pediatrics|October 23, 2003
Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccinationThomas V Adamkiewicz, Sharada Sarnaik, George R Buchanan, et al.
The New England Journal of Medicine|June 15, 2019
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell DiseaseElliott Vichinsky, Carolyn C Hoppe, Kenneth I Ataga, et al.
Blood|September 2, 2009
Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injuryThomas V Adamkiewicz, Miguel R Abboud, Carole Paley, et al.
Trials|August 16, 2023
Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trialChris A Rees, David C Brousseau, Daniel M Cohen, et al.
Pageof 14